A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
Clinical trial NCT07185776 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07185776
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-21
- Primary completion
- 2027-04-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.